Workstream 3 focuses on rare urogenital tumours. The Expertise Areas (EAs) covered by Workstream 3 are: A key part of EU health strategy is Europe’s Beating Cancer Plan, enhancing the cancer journey from prevention to survivorship. Network-generated literature underscores the effectiveness of a centralised approach for penile, testicular, adrenal, and soft tissue cancers. Specialised surgical training will increase organ preservation rates and decrease cancer mortality.
Workstream 3: Rare urogenital tumours
Leads
WS Lead: Hans Langenhuijsen
Clinical Lead: Dr. Peter-Paul M. Willemse
Dr. Peter-Paul M. Willemse is an oncological urologist at the University Medical Center Utrecht, where he is Head of the oncological urology board. His primary research focus is the diagnosis and treatment of urological malignancies. He is a member of the working group on Quality Assessment and the working group on Oncological Urology of the Dutch Urologic Association.Education Lead: Mariangela Mancini
Research Lead: Vacant
